Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2FO4

Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumor associated MUC1-8 peptide

2FO4 の概要
エントリーDOI10.2210/pdb2fo4/pdb
関連するPDBエントリー1G7Q
分子名称H-2 class I histocompatibility antigen, K-B alpha chain, Beta-2-microglobulin, 8-mer from Mucin-1, ... (8 entities in total)
機能のキーワードanchor modifications, h-2kb, muc1, non-canonical peptide, muc1-8, vaccine design, immune system
由来する生物種Mus musculus (house mouse)
詳細
タンパク質・核酸の鎖数3
化学式量合計45506.89
構造登録者
Lazoura, E.,Ramsland, P.A. (登録日: 2006-01-12, 公開日: 2006-11-14, 最終更新日: 2024-10-23)
主引用文献Lazoura, E.,Lodding, J.,Farrugia, W.,Ramsland, P.A.,Stevens, J.,Wilson, I.A.,Pietersz, G.A.,Apostolopoulos, V.
Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide
Immunology, 119:306-316, 2006
Cited by
PubMed Abstract: Designing peptide-based vaccines for therapeutic applications in cancer immunotherapy requires detailed knowledge of the interactions between the antigenic peptide and major histocompatibility complex (MHC) in addition to that between the peptide-MHC complex and the T-cell receptor. Past efforts to immunize with high-affinity tumour-associated antigenic peptides have not been very immunogenic, which may be attributed to the lack of T cells to these peptides, having been deleted during thymic development. For this reason, low-to-medium affinity non-canonical peptides represent more suitable candidates. However, in addition to the difficulty in identifying such antigens, peptide binding to MHC, and hence its ability to induce a strong immune response, is limited. Therefore, to enhance binding to MHC and improve immune responses, anchor modifications of non-canonical tumour-associated peptides would be advantageous. In this study, the non-canonical tumour-associated peptide from MUC1, MUC1-8 (SAPDTRPA), was modified at the MHC anchor residues to SAPDFRPL (MUC1-8-5F8L) and showed enhanced binding to H-2Kb and improved immune responses. Furthermore, the crystal structure of MUC1-8-5F8L in complex with H-2Kb was determined and it revealed that binding of the peptide to MHC is similar to that of the canonical peptide OVA8 (SIINFEKL).
PubMed: 17067310
DOI: 10.1111/j.1365-2567.2006.02434.x
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.7 Å)
構造検証レポート
Validation report summary of 2fo4
検証レポート(詳細版)ダウンロードをダウンロード

237423

件を2025-06-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon